World IP Review events - Updated agenda released for San Francisco Life Sciences Patent Conference
In the ever-evolving landscape of life science innovation, protecting your intellectual property is not just a box to check—it's a critical pathway to maximizing your impact and ROI. That's why the brightest minds are converging at LSPN Fall, where we'll map out a comprehensive strategy for bulletproofing your patents at every stage of the life cycle. From conception to commercialization, our lineup of heavy-hitters will equip you with the tools and tactics to safeguard your breakthroughs.
The Life Sciences Patent Network conference (October 15-16, Hyatt Regency San Francisco, Embarcadero district) presents a unique opportunity for the industry to come together and discuss what the current industry challenges are, and how they are overcoming them. The recently updated agenda shows the topics for discussion at the event in October.
View the timed agenda now
Delegates will hear real case studies from some of the most innovative and largest companies who are future-proofing their portfolio and leave with a clear blueprint for success as industry thought leaders share the strategies and tactics they have used to stay ahead of their competitors. When we asked our chairperson Eldora Ellison, Director, Sterne Kessler why she comes back to LSPN year after year she said “The LSPN conference provides a unique opportunity to gain in-depth knowledge on the cutting-edge issues that are most relevant to my practice. LSPN gives the attendees a deep dive into the patent law issues that impact practitioners in the life sciences in both the US and globally. Additionally, LSPN provides an unparalleled opportunity to network with colleagues and have small-group dialogues in the numerous round-table discussions.”
Attendees at the event will:
Join the discussion on the latest innovations in how to protect them with speakers from Pfizer, Bristol Myers Squibb, BioMarin, 10x Genomics, City of Hope, Illumina and more in keynote presentations and panel discussions.Hear from leaders from the industry including Randy Wu, Vice President of Intellectual Property and Litigation at 10x Genomics, Betsy Haane, SVP, Intellectual Property at IGM Biosciences, and Anand Viswanathan, Director, Intellectual Property at BioMarin Pharmaceuticals.Delve into pressing issues including AI, effective prosecution and enforcement strategies, and multi-jurisdiction challenges with thought leaders and experts in our deep-dive roundtable discussions.
And so much more.
View more on the event website here
We look forward to welcoming attendees to what promises to be the must attend event for pharma and biotech patent owners this year.
Hannah GoreSenior Conference ProducerWorld IP Reviewhgore@newtonmedia.co.uk
Distributed by https://pressat.co.uk/